Table 3.
Surface Modification | Incorporated Drug | Zero-Order | First-Order | Higuchi | Korsmeyer-Peppas | ||||
---|---|---|---|---|---|---|---|---|---|
k | r2 | k | r2 | k | r2 | n | r2 | ||
TL-PC | Cisplatin | 0.0725 | 0.8445 | 0.0008 | 0.5875 | 1.8554 | 0.8061 | 0.1248 | 0.9811 |
TL-PC-HDL | Cisplatin | 11.699 | 0.7284 | 0.0890 | 0.8478 | 30.162 | 0.9287 | 0.2716 | 0.9897 |
TL-PC | Paclitaxel | 0.0668 | 0.9127 | 0.0003 | 0.9313 | 1.294 | 0.9862 | 0.6787 | 0.9846 |
TL-PC-HDL | Paclitaxel | 0.5589 | 0.9869 | 0.0037 | 0.9589 | 5.8756 | 0.8766 | 1.1348 | 0.9891 |